{"title":"A retrospective study of association of CT severity with clinical profile and outcomes of patients with COVID-19 in the second wave","authors":"Neema Agarwal, P. Jain, T. Khan, A. Raja","doi":"10.25259/JCIS_11_2022","DOIUrl":null,"url":null,"abstract":"Objectives This study aimed to find out the association of CT severity score with demographic and clinical characteristics as well as mortality in the patients who were confirmed to have COVID-19 disease in the second wave. Material and Methods This retrospective study included collection and assessment of the demographic, clinical, laboratory data, and mortality of the patients, suspected with COVID-19 infection who underwent chest HRCT scan during March to April 2021. The findings of the chest HRCT were retrieved manually from the Medical Records section. Determination of the severity was done by the scoring system that involved the visual evaluation of the affected lobes. Results CT severity score was mild, moderate, and severe in 21.94%, 41.60%, and 30.48% patients, respectively. Mortality rate was 5.70%. Age of the patients with mild, moderate, and severe CT severity score was significantly more than those with normal severity score (50 vs. 50 vs. 50 vs. 31, P=0.0009). When compared to patients with normal score, those with mild, moderate, and severe CT severity score had significantly higher dyspnoea (10.39% vs. 67.81% vs. 97.20% vs. 0%), significantly more cases with diabetes mellitus (16.88% vs. 25.34% vs. 31.78% vs. 9.52%, P=0.044), hypertension (27.27% vs. 21.23% vs. 32.71% vs. 4.76%, P=0.026), and obesity (6.49% vs. 8.90% vs. 23.36% vs. 0%, P=0.0005). Total leucocyte counts, absolute neutrophil counts, creatinine, serum glutamic pyruvic transaminase (SGPT), lactate dehydrogenase (LDH), ferritin, and D-dimer were deranged in significantly more patients of severe score (53.27%, 62.62%, 60.75%, 85.05%, 90.65%, 97.20%, and 95.35%, respectively). Interleukin-6 (IL-6) and C-reactive protein were deranged in significantly more patients with moderate disease (98.18% and 98.63%, respectively). Increasing severity scores were associated with increased mortality (mild vs. moderate vs. severe: 1.30% vs. 1.37 vs. 15.89%, P<.0001). Oxygen saturation (SpO2) was significantly lowest in severe score followed by moderate, mild and normal scores (87 vs. 90 vs. 96 vs. 97, P<.0001). Duration of non-rebreather mask (NRBM), noninvasive ventilation (NIV), high-flow nasal cannula (HFNC), Venture/face mask, and intubation was also associated with increasing severity scores (P<0.0001). Conclusion CT scans play an important role in guiding physicians with their management plans and can serve as a predictor of disease severity and outcomes.","PeriodicalId":15512,"journal":{"name":"Journal of Clinical Imaging Science","volume":"95 1","pages":""},"PeriodicalIF":1.1000,"publicationDate":"2022-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Imaging Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25259/JCIS_11_2022","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 4
Abstract
Objectives This study aimed to find out the association of CT severity score with demographic and clinical characteristics as well as mortality in the patients who were confirmed to have COVID-19 disease in the second wave. Material and Methods This retrospective study included collection and assessment of the demographic, clinical, laboratory data, and mortality of the patients, suspected with COVID-19 infection who underwent chest HRCT scan during March to April 2021. The findings of the chest HRCT were retrieved manually from the Medical Records section. Determination of the severity was done by the scoring system that involved the visual evaluation of the affected lobes. Results CT severity score was mild, moderate, and severe in 21.94%, 41.60%, and 30.48% patients, respectively. Mortality rate was 5.70%. Age of the patients with mild, moderate, and severe CT severity score was significantly more than those with normal severity score (50 vs. 50 vs. 50 vs. 31, P=0.0009). When compared to patients with normal score, those with mild, moderate, and severe CT severity score had significantly higher dyspnoea (10.39% vs. 67.81% vs. 97.20% vs. 0%), significantly more cases with diabetes mellitus (16.88% vs. 25.34% vs. 31.78% vs. 9.52%, P=0.044), hypertension (27.27% vs. 21.23% vs. 32.71% vs. 4.76%, P=0.026), and obesity (6.49% vs. 8.90% vs. 23.36% vs. 0%, P=0.0005). Total leucocyte counts, absolute neutrophil counts, creatinine, serum glutamic pyruvic transaminase (SGPT), lactate dehydrogenase (LDH), ferritin, and D-dimer were deranged in significantly more patients of severe score (53.27%, 62.62%, 60.75%, 85.05%, 90.65%, 97.20%, and 95.35%, respectively). Interleukin-6 (IL-6) and C-reactive protein were deranged in significantly more patients with moderate disease (98.18% and 98.63%, respectively). Increasing severity scores were associated with increased mortality (mild vs. moderate vs. severe: 1.30% vs. 1.37 vs. 15.89%, P<.0001). Oxygen saturation (SpO2) was significantly lowest in severe score followed by moderate, mild and normal scores (87 vs. 90 vs. 96 vs. 97, P<.0001). Duration of non-rebreather mask (NRBM), noninvasive ventilation (NIV), high-flow nasal cannula (HFNC), Venture/face mask, and intubation was also associated with increasing severity scores (P<0.0001). Conclusion CT scans play an important role in guiding physicians with their management plans and can serve as a predictor of disease severity and outcomes.
目的探讨第二波新冠肺炎确诊患者CT严重程度评分与人口学特征、临床特征及死亡率的相关性。材料与方法本回顾性研究包括收集和评估2021年3月至4月期间接受胸部HRCT扫描的疑似COVID-19感染患者的人口学、临床、实验室数据和死亡率。胸部HRCT的结果是手动从“医疗记录”部分检索的。严重程度的确定是通过评分系统完成的,该评分系统包括对受影响的脑叶的视觉评估。结果CT严重程度评分为轻度的占21.94%,中度的占41.60%,重度的占30.48%。死亡率5.70%。轻、中、重度CT严重程度评分患者的年龄明显大于正常严重程度评分患者(50 vs. 50 vs. 50 vs. 31, P=0.0009)。与正常评分的患者相比,轻、中、重度CT严重程度评分的患者呼吸困难明显增加(10.39% vs. 67.81% vs. 97.20% vs. 0%),糖尿病(16.88% vs. 25.34% vs. 31.78% vs. 9.52%, P=0.044)、高血压(27.27% vs. 21.23% vs. 32.71% vs. 4.76%, P=0.026)、肥胖(6.49% vs. 8.90% vs. 23.36% vs. 0%, P=0.0005)发生率明显增加。白细胞总计数、绝对中性粒细胞计数、肌酐、血清谷丙转氨酶(SGPT)、乳酸脱氢酶(LDH)、铁蛋白和d -二聚体紊乱在重度患者中显著高于对照组(分别为53.27%、62.62%、60.75%、85.05%、90.65%、97.20%和95.35%)。白介素-6 (IL-6)和c反应蛋白紊乱在中度疾病患者中显著增加(分别为98.18%和98.63%)。加重评分与死亡率增加相关(轻度、中度、重度:1.30%、1.37、15.89%,P< 0.0001)。重度评分的血氧饱和度(SpO2)最低,其次是中度、轻度和正常评分(87 vs. 90 vs. 96 vs. 97, P< 0.0001)。非呼吸面罩(NRBM)、无创通气(NIV)、高流量鼻插管(HFNC)、Venture/面罩和插管的持续时间也与严重程度评分增加相关(P<0.0001)。结论CT扫描对指导医生制定治疗方案具有重要作用,可作为疾病严重程度和预后的预测指标。
期刊介绍:
The Journal of Clinical Imaging Science (JCIS) is an open access peer-reviewed journal committed to publishing high-quality articles in the field of Imaging Science. The journal aims to present Imaging Science and relevant clinical information in an understandable and useful format. The journal is owned and published by the Scientific Scholar. Audience Our audience includes Radiologists, Researchers, Clinicians, medical professionals and students. Review process JCIS has a highly rigorous peer-review process that makes sure that manuscripts are scientifically accurate, relevant, novel and important. Authors disclose all conflicts, affiliations and financial associations such that the published content is not biased.